15 December 2024
: Case report 
Diagnostic Challenges in Malignant Hyperthermia and Anesthesia-Induced Rhabdomyolysis: A Case Study
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Unexpected drug reaction, Rare disease
Maya Belitova
ABCDEFG 1*, Gergana Georgieva Nikolova BCDF 1, Slavyana Usheva ABCDEF 2, Maya Todorova Mladenova BCDEFG 1, Tsvetomir Marinov BCE 1, Radka Kaneva CDE 3, Theophil Sedloev ABCDEFG 2
DOI: 10.12659/AJCR.946306
Am J Case Rep 2024; 25:e946306
Table 2. Biochemical analysis of the patient with malignant hyperthermia.
| Parameter (units) | 30 Min. after ETI | 40 Min. after ETI | 4 h after ETI admission in ICU; FiO2 50% | 24 h after ETI; FiO2 21% | 48 h after ETI; FiO2 21% | Postoperative Day 7 | Reference values |
|---|---|---|---|---|---|---|---|
| Potassium (mmol/L) | 5.1 | 4.9 | 3.7 | 3.5 | 3.4 | 3.7 | 3.5–5.1 |
| Creatine kinase (U/L) | 1579 | 2713 | 16 268 | >37 000 | >37 000 | 2658 | 25–170 |
| Creatinine (umol/L) | 102 | 101 | 101 | 68 | 68 | 88 | 40–120 |
| FiO – fraction of inspired oxygen; ETI – endotracheal intubation. | |||||||